Contact Us


Your Name (required)

Your Email (required)

Subject

Your Message

Newsletter

ADVANCE – The Official Newsletter of WDSrx (Q4 2017)

Read and Download the Full Advance Newsletter (Q4 2017) Here Take a look at our internal newsletter. The theme of this 4th quarter issue is, “Branching Out” with a featured letter from President Adam Runsdorf. Other articles include: Expert Advice on Vendor Managed Inventory Facilities Focus WDSrx Family Photos Daniela’s Healthy Palette WDSrx-posé featuring Warehouse Manager Jason Ferrara Branching Out WDSrx Social Media Feed     This Issue of Advance Was Created and...

WDSrx Monthly News Update August 2017

WDSrx gets published on DC Velocity, sponsors an HDA Serialization Survey, attends NACDS this month and welcomes a new member of our business development team. Read our monthly update for details. ...

Advance – The Official Newsletter Of WDSrx (2nd Edition Q4 2016)

Leadership Letter Adam Runsdorf, President The pharmaceutical Third Party Logistics industry is undergoing significant change. The way we choose to address these changes is the difference between facing challenges or creating opportunities. This issue of Advance focuses on our plans to comply with new rules that are part of the Drug Supply Chain and Security Act, or DSCSA.  The law, signed in 2014, requires that all prescription drug products down to the smallest saleable unit (SSU) be electron...

Advance – WDSrx Newsletter – Launch Issue

The Newsletter of Woodfield Distribution, LLC – Launch Issue V.2016 No. Q2 LEADERSHIP LETTER: PRESIDENT ADAM RUNSDORF Welcome to the launch issue of ADVANCE.  WDSrx continues to advance our expertise within the pharmaceutical logistics industry.  Our strategy for measured growth is entering a new phase as we add new team members, new facilities, new technology and equipment to meet our business objectives.  As WDSrx evolves, it is important to maintain the company’s principles and val...

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.